Table 3.
Target microbes | YAK (zone of inhibition, mm) | AI | BAK (zone of inhibition, mm) | AI |
---|---|---|---|---|
Aeromonas hydrophila SBK1 | ND | – | ND | – |
Salmonella typhi B3274 | ||||
6.5 ± 0.6, | 0.56 | ND | – | |
Salmonella typhi E1590 | ||||
6.0 ± 0.6 | 0.36 | 3.5 ± 0.3 | 0.21 | |
Salmonella typhi MTCC 734 | 5.5 ± 0.4 | 0.47 | 4.5 ± 0.4 | 0.39 |
Shigella dysenteriae 4717 | ||||
5.2 ± 1.04 | 0.46 | 5.5 ± 0.5 | 0.49 | |
Shigella sonnei RS 1 | ||||
ND | – | ND | – | |
Staphylococcus aureus MB 13 | ||||
7.5 ± 0.8 | 0.63 | ND | – | |
Streptococcus faecalis MB 15 | ||||
6.2 ± 0.6 | 0.65 | ND | – | |
Micrococcus luteus ATCC 9341 | ||||
7.0 ± 0.6 | 0.56 | 7.2 ± 0.7 | 0.58 | |
Vibrio harveyi MTCC 7954 | ||||
8.5 ± 0.8 | 0.94 | 6.5 ± 0.7 | 0.76 |
Data are presented as means ± standard deviation of three replicates. Activity index (AI) = inhibitory zone of test sample (excluding disc diameter, 5 mm)/inhibitory zone of a standard drug (tetracycline, 10 mg/disc).